Supplementary data, Figure 3 from Bruton's Tyrosine Kinase Inhibitors Prevent Therapeutic Escape in Breast Cancer Cells
Year: 2023
Type: supplementary-materials
Abstract: Live cell count assay showing the EGF effects on drug-treated BT474 and SKBR3 cells(72h), complete rescue, lapatinib (Lap) with EGF treatment; no rescue lapatinib, ibrutinib(Ibr) and ibrutinib with EGF treatment.
Authors: Xianhui Wang, Jason Wong, Christopher J. Sevinsky, Leila Kokabee, Faiza Khan, Yan Sun, Douglas S. Conklin
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362527028
